Tobacco smoking and tobacco cessation in 2018
Memo, OFDT, 4 p.
In the wake of the 2017 findings, the year 2018 was marked by a sharp decline in cigarette and of roll-your-own tobacco sales in France’s tobacconist network. However, a slight increase in other types of tobacco, less heavily taxed, can be seen, together with a likely increase in cross-border purchases.
In addition, all indicators related to quitting smoking are noticeably on the up, even more so than in 2017. Sales of treatments to help people quit smoking are at an all-time high, boosted by the implementation during the year of the systematic and non-capped reimbursement of prescribed tobacco cessation treatments. Moreover, use of the Tobacco Information Service telephone helpline/website continues to intensify and the third edition of #MoisSansTabac has confirmed the operation’s status as a highlight for smoking cessation among French smokers.
Author : Aurélie Lermenier-Jeannet
Download the PDF file (517 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.